New nursing protocol aims to stop deadly clots after heart surgery

NCT ID NCT07347652

First seen Jan 21, 2026 · Last updated Jun 22, 2026 · Updated 20 times

Summary

This study tests whether a special nursing care protocol can prevent deep vein thrombosis (DVT) in 67 adults undergoing on-pump cardiac surgery. One group gets the new protocol, which includes devices to improve blood flow, blood thinners, early walking, hydration, and patient education, while the other gets standard care. The goal is to see fewer blood clots in the protocol group over three months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ON-PUMP CARDIAC SURGERY - PREVENTION - INTERVENTION - EXPERIMENTAL GROUP - CONTROL GROUP - INCIDENCE - COMPLICATIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Facility of Nursing

    Nicosia, Cyprus

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

nursing care protocol (including IPC devices, anticoagulant therapy, early identification, ambulation, hydration, and patient education)

What this could lead to

If successful, this could provide a simple, evidence-based nursing protocol to significantly reduce dangerous blood clots after heart surgery.

What could go wrong

This is a small, single-center study with only 67 participants, so results may not apply to all hospitals or patients. The protocol combines several steps, making it hard to know which part works best.

Conditions

The condition(s) this trial relates to.

venous thromboembolism Venous Thrombosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.